Paper19920109
DNA replication licensing factors and aneuploidy are linked to tumor cell cycle state and clinical outcome in penile carcinoma.
Kayes OJ and 10 others. Clin Cancer Res, 2009. Cited by 26 papers, by iCite.
Cite this record
ConductScience Library. DNA replication licensing factors and aneuploidy are linked to tumor cell cycle state and clinical outcome in penile carcinoma. Papers, record 19920109. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/19920109
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- DNA replication licensing factors and aneuploidy are linked to tumor cell cycle state and clinical outcome in penile carcinoma.
- PubMed
Topics20
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Aneuploidy | Major topic |
| Carcinoma | Major topic |
| Gene Expression Regulation, Neoplastic | Major topic |
| Penile Neoplasms | Major topic |
| Adult | |
| Aged | |
| Aged, 80 and over | |
| Cell Cycle | |
| Cell Cycle Proteins | |
| Cohort Studies | |
| Geminin | |
| Gene Expression Profiling | |
| Humans | |
| Ki-67 Antigen | |
| Male | |
| Middle Aged | |
| Minichromosome Maintenance Complex Component 2 | |
| Nuclear Proteins | |
| Ploidies | |
| Treatment Outcome |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| A6263 | Cancer Research UK | United Kingdom | PubMed |
Source PubMed
References50
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 17947481 | DNA replication licensing factors and aurora kinases are linked to aneuploidy and clinical outcome in epithelial ovarian carcinoma. | Clin Cancer Res | 2007 | https://conductscience.org/library/papers/17947481 | PubMed |
| 2 | 16005865 | Repression of DNA replication licensing in quiescence is independent of geminin and may define the cell cycle state of progenitor cells. | Exp Cell Res | 2005 | https://conductscience.org/library/papers/16005865 | PubMed |
| 3 | 8437253 | Squamous cell carcinoma of the penis. III. Treatment of regional lymph nodes. | J Urol | 1993 | https://conductscience.org/library/papers/8437253 | PubMed |
| 4 | 11555583 | Minichromosome maintenance protein 2 expression in prostate: characterization and association with outcome after therapy for cancer. | Clin Cancer Res | 2001 | https://conductscience.org/library/papers/11555583 | PubMed |
| 5 | 12966424 | Aberrant expression of minichromosome maintenance protein-2 and Ki67 in laryngeal squamous epithelial lesions. | Br J Cancer | 2003 | https://conductscience.org/library/papers/12966424 | PubMed |
| 6 | 16925747 | A prospective study of 100 cases of penile cancer managed according to European Association of Urology guidelines. | BJU Int | 2006 | https://conductscience.org/library/papers/16925747 | PubMed |
| 7 | 12612656 | Translational approaches to improving cervical screening. | Nat Rev Cancer | 2003 | https://conductscience.org/library/papers/12612656 | PubMed |
| 8 | 10551502 | Immunoassay for urothelial cancers that detects DNA replication protein Mcm5 in urine. | Lancet | 1999 | https://conductscience.org/library/papers/10551502 | PubMed |
| 9 | 18488006 | Stopping replication, at the beginning. | Nat Chem Biol | 2008 | https://conductscience.org/library/papers/18488006 | PubMed |
| 10 | 18843031 | Improved screening for anal neoplasia by immunocytochemical detection of minichromosome maintenance proteins. | Cancer Epidemiol Biomarkers Prev | 2008 | https://conductscience.org/library/papers/18843031 | PubMed |
| 11 | 14645419 | Minichromosome maintenance protein 2 is a strong independent prognostic marker in breast cancer. | J Clin Oncol | 2003 | https://conductscience.org/library/papers/14645419 | PubMed |
| 12 | 19318489 | Cdc7 kinase is a predictor of survival and a novel therapeutic target in epithelial ovarian carcinoma. | Clin Cancer Res | 2009 | https://conductscience.org/library/papers/19318489 | PubMed |
| 13 | 11849970 | Replication licensing--defining the proliferative state? | Trends Cell Biol | 2002 | https://conductscience.org/library/papers/11849970 | PubMed |
| 14 | 15814627 | Mcm2, Geminin, and KI67 define proliferative state and are prognostic markers in renal cell carcinoma. | Clin Cancer Res | 2005 | https://conductscience.org/library/papers/15814627 | PubMed |
| 15 | 18425779 | Surgical treatment of invasive squamous cell carcinoma of the penis: Brazilian National Cancer Institute long-term experience. | J Surg Oncol | 2008 | https://conductscience.org/library/papers/18425779 | PubMed |
| 16 | 8306161 | Morbidity following groin dissection for penile carcinoma. | Br J Urol | 1993 | https://conductscience.org/library/papers/8306161 | PubMed |
| 17 | 18756287 | Replication licensing and cancer--a fatal entanglement? | Nat Rev Cancer | 2008 | https://conductscience.org/library/papers/18756287 | PubMed |
| 18 | 12107111 | Expression of geminin as a marker of cell proliferation in normal tissues and malignancies. | Am J Pathol | 2002 | https://conductscience.org/library/papers/12107111 | PubMed |
| 19 | 9857179 | Cdc6 protein causes premature entry into S phase in a mammalian cell-free system. | EMBO J | 1998 | https://conductscience.org/library/papers/9857179 | PubMed |
| 20 | 18414413 | Diagnosis of pancreaticobiliary malignancy by detection of minichromosome maintenance protein 5 in bile aspirates. | Br J Cancer | 2008 | https://conductscience.org/library/papers/18414413 | PubMed |
Cited by11
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 26 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41333157 | Integrative Multi-Omics and Functional Characterization Reveal MCM4 as a Key Oncogenic Regulator in Hepatocellular Carcinoma. | Onco Targets Ther | 2025 | https://conductscience.org/library/papers/41333157 | PubMed |
| 37587215 | Comparing predictions among competing risks models with rare events: application to KNOW-CKD atudy-a multicentre cohort study of chronic kidney disease. | Sci Rep | 2023 | https://conductscience.org/library/papers/37587215 | PubMed |
| 36505293 | Molecular subtypes of cuproptosis regulators and their correlation with clinical prognosis and immune response in glioma. | Am J Transl Res | 2022 | https://conductscience.org/library/papers/36505293 | PubMed |
| 29721062 | Expression of Minichromosome Maintenance Proteins (MCM) and Cancer Prognosis: A meta-analysis. | J Cancer | 2018 | https://conductscience.org/library/papers/29721062 | PubMed |
| 29470654 | [Molecular characterization of penile cancer : Literature review of new prognostic markers and potential therapeutic targets]. | Urologe A | 2018 | https://conductscience.org/library/papers/29470654 | PubMed |
| 26514699 | Review and evaluation of penalised regression methods for risk prediction in low-dimensional data with few events. | Stat Med | 2016 | https://conductscience.org/library/papers/26514699 | PubMed |
| 25386362 | MCM Paradox: Abundance of Eukaryotic Replicative Helicases and Genomic Integrity. | Mol Biol Int | 2014 | https://conductscience.org/library/papers/25386362 | PubMed |
| 23819610 | Cytosolic phosphorylated EGFR is predictive of recurrence in early stage penile cancer patients: a retropective study. | J Transl Med | 2013 | https://conductscience.org/library/papers/23819610 | PubMed |
| 23293117 | Penile cancer: current therapy and future directions. | Ann Oncol | 2013 | https://conductscience.org/library/papers/23293117 | PubMed |
| 23132171 | Male genital premalignant dermatoses. | Curr Urol Rep | 2012 | https://conductscience.org/library/papers/23132171 | PubMed |
| 21957244 | Activation of postnatal neural stem cells requires nuclear receptor TLX. | J Neurosci | 2011 | https://conductscience.org/library/papers/21957244 | PubMed |
Genes10
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CD33 | 945 | PubTator's text mining | https://conductscience.org/library/genes/945 | NCBI Gene |
| CD34 | 947 | PubTator's text mining | https://conductscience.org/library/genes/947 | NCBI Gene |
| CDC6 | 990 | PubTator's text mining | https://conductscience.org/library/genes/990 | NCBI Gene |
| CDT1 | 81620 | PubTator's text mining | https://conductscience.org/library/genes/81620 | NCBI Gene |
| CISH | 1154 | PubTator's text mining | https://conductscience.org/library/genes/1154 | NCBI Gene |
| GMNN | 51053 | PubTator's text mining | https://conductscience.org/library/genes/51053 | NCBI Gene |
| MCM2 | 4171 | PubTator's text mining | https://conductscience.org/library/genes/4171 | NCBI Gene |
| MIB1 | 57534 | PubTator's text mining | https://conductscience.org/library/genes/57534 | NCBI Gene |
| PIK3CA | 5290 | PubTator's text mining | https://conductscience.org/library/genes/5290 | NCBI Gene |
| RLF | 6018 | PubTator's text mining | https://conductscience.org/library/genes/6018 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/19920109
GET https://conductscience.org/api/papers/v1/19920109/references?page=2